X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (357) 357
Publication (15) 15
Book Chapter (5) 5
Book / eBook (3) 3
Book Review (3) 3
Web Resource (3) 3
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (172) 172
male (109) 109
female (107) 107
middle aged (95) 95
oncology (74) 74
aged (73) 73
adult (72) 72
index medicus (72) 72
treatment outcome (49) 49
hematology (44) 44
chemotherapy (42) 42
cancer (38) 38
pancreatic cancer (31) 31
therapy (29) 29
aged, 80 and over (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (28) 28
gemcitabine (28) 28
surgery (28) 28
risk factors (25) 25
peripheral vascular disease (24) 24
survival (24) 24
care and treatment (22) 22
deoxycytidine - analogs & derivatives (22) 22
pancreatic neoplasms - drug therapy (22) 22
medicine & public health (19) 19
prognosis (18) 18
prospective studies (18) 18
transplantation (18) 18
drug therapy (17) 17
germany (17) 17
immunology (17) 17
retrospective studies (17) 17
anticoagulants - administration & dosage (16) 16
colorectal cancer (16) 16
fluorouracil (16) 16
fluorouracil - administration & dosage (16) 16
antineoplastic agents - therapeutic use (15) 15
disease-free survival (15) 15
further section · weitere sektionen (15) 15
pancreatic neoplasms - pathology (15) 15
rituximab (15) 15
time factors (15) 15
venous thromboembolism (15) 15
anticoagulants - adverse effects (14) 14
carcinoma (14) 14
leucovorin - administration & dosage (14) 14
neoplasm staging (14) 14
survival analysis (14) 14
antineoplastic combined chemotherapy protocols - administration & dosage (13) 13
cancer research (13) 13
clinical trials (13) 13
combined modality therapy (13) 13
deep-vein thrombosis (13) 13
deoxycytidine - administration & dosage (13) 13
follow-up studies (13) 13
hemorrhage - chemically induced (13) 13
molecular-weight heparin (13) 13
tumors (13) 13
adenocarcinoma (12) 12
analysis (12) 12
anticoagulants - therapeutic use (12) 12
chemotherapy, adjuvant (12) 12
disease progression (12) 12
liver neoplasms - secondary (12) 12
lymphoproliferative disorders - drug therapy (12) 12
patients (12) 12
research (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
kaplan-meier estimate (11) 11
leucovorin (11) 11
liver neoplasms - drug therapy (11) 11
liver transplantation - adverse effects (11) 11
organ transplantation - adverse effects (11) 11
5-fluorouracil (10) 10
antimetabolites, antineoplastic - therapeutic use (10) 10
diagnosis (10) 10
drug administration schedule (10) 10
lymphoma (10) 10
lymphoproliferative disorders - etiology (10) 10
pancreatic neoplasms - mortality (10) 10
prophylaxis (10) 10
survival rate (10) 10
thromboembolism (10) 10
trial (10) 10
venous thromboembolism - prevention & control (10) 10
administration, oral (9) 9
cancer patients (9) 9
cancer therapies (9) 9
colorectal neoplasms - drug therapy (9) 9
colorectal neoplasms - pathology (9) 9
deoxycytidine - therapeutic use (9) 9
disease (9) 9
gastroenterology & hepatology (9) 9
genetics (9) 9
heparin, low-molecular-weight - administration & dosage (9) 9
hyperthermia, induced (9) 9
lymphomas (9) 9
neoplasms - drug therapy (9) 9
organoplatinum compounds - administration & dosage (9) 9
prevention (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2008, Recent results in cancer research, ISBN 3540712666, Volume 177, xi, 185
High level academic ebook 
Pancreas | Cancer | Medicine & Public Health | Oncology | Gastroenterology
Book
Journal of Clinical Oncology, ISSN 0732-183X, 02/2016, Volume 34, Issue 5, pp. 516 - 517
Journal Article
Laryngo- Rhino- Otologie, ISSN 0935-8943, 10/2015, Volume 94, Issue 10, pp. 697 - 709
Journal Article
Perfusion (Germany), ISSN 0935-0020, 02/2017, Volume 30, Issue 1, pp. 20 - 21
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 2, pp. 196 - 206
Summary Background Post-transplantation lymphoproliferative disorder (PTLD) develops in 1–10% of transplant recipients and can be Epstein–Barr virus (EBV)... 
Hematology, Oncology and Palliative Medicine | SOLID-ORGAN TRANSPLANTATION | VIRAL LOAD | THERAPY | MANAGEMENT | REDUCTION | ONCOLOGY | IMMUNOSUPPRESSION | DISEASE | LYMPHOMA | RISK | EPSTEIN-BARR-VIRUS | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Organ Transplantation - pathology | Cyclophosphamide - therapeutic use | Epstein-Barr Virus Infections - therapy | Vincristine - administration & dosage | Adult | Female | Herpesvirus 4, Human - pathogenicity | Prednisolone - therapeutic use | France | Lymphoproliferative Disorders - etiology | Doxorubicin - administration & dosage | Antigens, CD20 - immunology | Rituximab | Lymphoproliferative Disorders - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Organ Transplantation - adverse effects | Adolescent | Vincristine - therapeutic use | Epstein-Barr Virus Infections - diagnosis | Lymphoproliferative Disorders - drug therapy | Aged | Germany | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Anthracyclines | Cyclophosphamide | Chemotherapy | Corticosteroids | Organ transplant recipients | Clinical trials | Product development | Epstein-Barr virus | Universities and colleges | Prednisolone | Cancer | Antibodies, Monoclonal, Murine-Derived | Antigens, CD20 | Lymphoproliferative Disorders | Antineoplastic Combined Chemotherapy Protocols | Organ Transplantation | Vincristine | Doxorubicin | Herpesvirus 4, Human | Life Sciences | Immunology | Epstein-Barr Virus Infections
Journal Article
Lancet Neurology, The, ISSN 1474-4422, 2013, Volume 12, Issue 7, pp. 677 - 688
Journal Article
Klinische Monatsblätter für Augenheilkunde, 04/2014, Volume 231, Issue 4, pp. e23 - e35
Journal Article
Klinische Monatsblatter fur Augenheilkunde, ISSN 0023-2165, 2014, Volume 231, Issue 4, pp. e23 - e36
Journal Article
DMW - Deutsche Medizinische Wochenschrift, ISSN 0012-0472, 12/2015, Volume 140, Issue 24, pp. 1813 - 1816
Zusammenfassung Das Adenokarzinom des Pankreas stellt eine der prognostisch ungünstigsten Tumorentitäten dar. In Deutschland ist das Pankreaskarzinom... 
Klinischer Fortschritt | treatment | pancreatic cancer | chemotherapy | prophylaxis
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 13, pp. 1310 - 1319
Journal Article
Uro-News, ISSN 1432-9026, 07/2014, Volume 18, Issue 7-8, pp. 36 - 40
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2019, Volume 380, Issue 8, pp. 720 - 728
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e18855 - e18855
Journal Article
Im Focus Onkologie, ISSN 1435-7402, 12/2013, Volume 16, Issue 12, pp. 49 - 52
Journal Article
Journal Article
by Wasan, Harpreet and Wasan, Harpreet S and Gibbs, Peter and Sharma, Navesh K and Sharma, Navesh and Sharma, Ricky A and Taieb, Julien and Heinemann, Volker and Ricke, Jens and Peeters, Marc and Findlay, Michael and Weaver, Andrew and Mills, Jamie and Wilson, Charles and Wilson, Greg and Adams, Richard and Francis, Anne and Moschandreas, Joanna and Virdee, Pradeep S and Dutton, Peter and Love, Sharon and Gebski, Val and Gray, Alastair and Bateman, Andrew and Blesing, Claire and Brown, Ewan and Brown, Michael and Chau, Ian and Cummins, Sebastian and Cunningham, David and Falk, Stephen and Hadaki, Maher and Hall, Marcia and Hickish, Tamas and Hornbuckle, Joanne and Lofts, Fiona and Lowndes, Sarah and Mayer, Astrid and Metcalfe, Matthew and Middleton, Gary and Montazeri, Amir and Muirhead, Rebecca and Polychronis, Andreas and Purcell, Colin and Ross, Paul and Sherwin, Liz and Smith, Randall and Smith, David and Smith, Denis and Soomal, Rubin and Swinson, Daniel and Walther, Axel and Amin, Pradip and Angelelli, Bruna and Balosso, Jacques and Beny, Alex and Bloomgarden, Daniel and Boucher, Evelyn and Bruch, Harald-Robert and Bui, James and Burge, Matthew and Burge, Mathew and Cardaci, Giuseppe and Carlisle, James and Chai, Seungjean and Chen, Yi-Jen and Chevallier, Patrick and Chuong, Michael and Clarke, Stephen and Coveler, Andrew and Craninx, Michael and Delanoit, Thierry and Deleporte, Amelie and Deleporte, Amélie and Eliadis, Paul and Facchini, Francis and Ferguson, Tom and Ferguson, Thomas and Ferrante, Michel and Frenette, Gary and Frick, Jacob and Ganju, Vinod and Garofalo, Michael and Geboes, Karen and Gehbauer, Gerald and George, Benjamin and Geva, Ravit and Gordon, Michael and Gregory, Kate and Gulec, Seza and Hannigan, James and van Hazel, Guy and Heching, Norman and Helmberger, Thomas and Hendlisz, Alain and Hendrickx, Koen and Holtzman, Matthew and Isaacs, Richard and Jackson, Christopher and James, Philip and ... and FOXFIRE Trial Investigators and FOXFIRE-Global Trial Investigators and SIRFLOX Trial Investigators and SIRFLOX trial investigators and FOXFIRE trial investigators and FOXFIRE-Global trial investigators
The Lancet Oncology, ISSN 1470-2045, 09/2017, Volume 18, Issue 9, pp. 1159 - 1171
Journal Article